The FOXM1 gene has been reported to overexpress in aggressive, therapy-resistant variants of hormone receptor-positive and triple-negative breast tumors and correlated with a poor prognosis in a variety of cancers, such as breast cancer and colorectal cancer25–27. Here, NR4A1 is linked to breast carcinoma.